Dr. Lal PathLabs Limited (NSE: LALPATHLAB)

Market Cap	281.46B
Revenue (ttm)	22.88B
Net Income (ttm)	3.82B
Shares Out	83.31M
EPS (ttm)	45.81
PE Ratio	73.75
Forward PE	62.26
Dividend	24.00 (0.71%)
Ex-Dividend Date	Aug 20, 2024

Volume	137,831
Open	3,424.00
Previous Close	3,404.50
Day's Range	3,363.95 - 3,449.50
52-Week Range	1,943.70 - 3,459.40
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Dr. Lal PathLabs

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1949
• Employees: 4,099
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LALPATHLAB

Financial Performance

In 2023, LALPATHLAB's revenue was 22.27 billion, an increase of 10.40% compared to the previous year's 20.17 billion. Earnings were 3.58 billion, an increase of 49.78%.